ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Combining drugs that target BRAF and HSP90 shows success for melanoma patients
April 26, 2018Scientists have tried combining drugs in an effort to prevent resistance development that eventually leads to cancer regrowth in melanoma patients. -
MK-8353 shows promise for melanoma with BRAF or RAS mutations
February 28, 2018An investigational compound designed to block a hyperactive cell growth signal in advanced melanoma and other cancers has shown some promise in an early-stage clinical trial… -
Horizon Discovery introduces four BRAF resistant melanoma PDX models
June 08, 2017PDX models of tumors offer better in vivo insights for cancer research and drug development. These highly characterized models were originally exclusively licensed from The Wistar Insitute
Pharma Sources Insight January 2025
